Actuate Therapeutics (ACTU) Financials: Revenue & Earnings

ACTU price $0.38 -0.02 -4.06%

Ticker
ACTU
Price
$0.38
Change
-0.02 -4.06%
Market cap ?
$9.20M
P/E ?
-0.53
Forward P/E ?
0.30
Dividend yield ?
0.00%
Beta ?
0.78
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
58
Quality
40
Growth
100

Stocklytics score rationale: value 58, quality 40, growth 100.

Financials

2022202320242025
0000

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma…

Fair value

ACTU fair value $50.04. Price $0.38. Price is 99% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ACTU

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.18——
2026-08-14-0.20-0.20——
2026-05-14-0.24-0.23——
2026-03-26-0.18-0.24——
2025-11-13-0.25-0.27——
2025-08-14-0.30-0.19——
2025-05-15-0.32-0.30——
2025-03-13-0.33-0.29——
2024-11-13-0.55-0.55——
2024-09-24-4.20———
2024-05-24-0.54———
2023-12-31-0.50———
2023-09-30-0.41———
2023-06-30-0.39———
2023-03-31-0.39———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-14SCHMITT DANIEL MBuy272.06K——
2026-08-14SCHMITT DANIEL MSell120.52K$1.01121.73K
2026-08-14SCHMITT DANIEL MSell272.06K——
2026-05-21Zabrowski DanBuy15.00K$2.4236.30K
2026-05-21THOMSON TODD SBuy15.00K$2.4236.30K
2026-05-21Sawhney RogerBuy15.00K$2.4236.30K
2026-05-21RONNEBERG AMY LBuy15.00K$2.4236.30K
2026-05-21Keyes Jason ABuy15.00K$2.4236.30K
2026-05-21Huber Martin H. Jr.Buy15.00K$2.4236.30K
2026-05-21Fletcher Aaron G.L.Buy15.00K$2.4236.30K
2026-05-01Huber Martin H. Jr.Other30.00K$3.0090.00K
2026-04-01SCHMITT DANIEL MBuy237.00K$2.49590.13K
2026-04-01Mazar Andrew PaulBuy105.00K$2.49261.45K
2026-04-01LYTLE PAUL JBuy105.00K$2.49261.45K
2026-02-13SCHMITT DANIEL MSell272.06K——
2026-02-13SCHMITT DANIEL MBuy272.06K——
2026-02-13SCHMITT DANIEL MSell121.87K$4.33527.71K
2026-01-05THOMSON TODD SSell280.00K$5.801.62M
2025-06-27Bios Equity COF, LPBuy71.43K$7.00500.00K
2025-06-27Bios Equity COF, LPBuy71.43K$7.00500.00K
2025-06-27Kreis Leslie W.Buy71.43K$7.00500.00K
2025-06-27Kreis Leslie W.Buy71.43K$7.00500.00K
2025-06-27Fletcher Aaron G.L.Buy71.43K$7.00500.00K
2025-06-27Fletcher Aaron G.L.Buy71.43K$7.00500.00K
2025-05-22THOMSON TODD SBuy15.00K$10.10151.50K
2025-05-22Sawhney RogerBuy15.00K$10.10151.50K
2025-05-22Zabrowski DanBuy15.00K$10.10151.50K
2025-05-22Fletcher Aaron G.L.Buy15.00K$10.10151.50K
2025-05-22Keyes Jason ABuy15.00K$10.10151.50K
2025-05-22RONNEBERG AMY LBuy15.00K$10.10151.50K
2025-04-01SCHMITT DANIEL MBuy204.28K$6.701.37M
2025-04-01SCHMITT DANIEL MBuy66.50K$6.70445.57K
2025-04-01Mazar Andrew PaulBuy110.35K$6.70739.32K
2025-04-01Mazar Andrew PaulBuy51.05K$6.70342.01K
2025-04-01LYTLE PAUL JBuy49.39K$6.70330.94K
2025-04-01LYTLE PAUL JBuy41.90K$6.70280.72K
2024-08-14Bios Equity COF, LPSell17.36K$8.00138.89K
2024-08-14Bios Equity COF, LPSell5.31K$8.0042.51K
2024-08-14Bios Equity COF, LPSell2.32K$8.0018.59K
2024-08-14Fletcher Aaron G.L.Sell17.36K$8.00138.89K
2024-08-14Fletcher Aaron G.L.Sell5.31K$8.0042.51K
2024-08-14Fletcher Aaron G.L.Sell2.32K$8.0018.59K
2024-08-14Kreis Leslie W.Sell17.36K$8.00138.89K
2024-08-14Kreis Leslie W.Sell5.31K$8.0042.51K
2024-08-14Kreis Leslie W.Sell2.32K$8.0018.59K
2024-08-14THOMSON TODD SBuy28.46K$5.27150.01K
2024-08-14THOMSON TODD SSell18.75K$8.00150.00K
2024-08-14THOMSON TODD SBuy69.44K——
2024-08-14THOMSON TODD SBuy1.06M——
2024-08-14THOMSON TODD SBuy146.87K——
2024-08-14THOMSON TODD SBuy726.16K——
2024-08-14THOMSON TODD SBuy49.98K——
2024-08-14THOMSON TODD SBuy132.91K——
2024-08-14THOMSON TODD SBuy24.14K——
2024-08-14THOMSON TODD SBuy230.60K——
2024-08-14THOMSON TODD SBuy138.89K——
2024-08-14THOMSON TODD SBuy726.16K——
2024-08-14THOMSON TODD SBuy1.06M——
2024-08-14THOMSON TODD SBuy138.89K——
2024-08-14THOMSON TODD SBuy132.91K——
2024-08-14THOMSON TODD SBuy49.98K——
2024-08-14THOMSON TODD SBuy28.46K$5.27150.01K
2024-08-14Bios Equity COF, LPBuy484.64K——
2024-08-14Bios Equity COF, LPBuy2.09M——
2024-08-14Bios Equity COF, LPBuy2.02M——
2024-08-14Bios Equity COF, LPBuy375.00K$8.003.00M
2024-08-14Bios Equity COF, LPBuy26.36K$5.27138.89K
2024-08-14Bios Equity COF, LPSell17.36K$9.00156.25K
2024-08-14Bios Equity COF, LPBuy332.87K——
2024-08-14Bios Equity COF, LPBuy884.43K——
2024-08-14Bios Equity COF, LPBuy176.50K——
2024-08-14Bios Equity COF, LPBuy573.39K——
2024-08-14Bios Equity COF, LPBuy525.80K——
2024-08-14Bios Equity COF, LPBuy462.07K——
2024-08-14Bios Equity COF, LPBuy78.27K——
2024-08-14Bios Equity COF, LPBuy74.20K——
2024-08-14Bios Equity COF, LPBuy326.55K——
2024-08-14Bios Equity COF, LPBuy309.59K——
2024-08-14Bios Equity COF, LPBuy307.54K——
2024-08-14Bios Equity COF, LPBuy8.07K$5.2742.52K
2024-08-14Bios Equity COF, LPBuy147.05K——
2024-08-14Bios Equity COF, LPSell5.31K$9.0047.83K
2024-08-14Bios Equity COF, LPBuy101.90K——
2024-08-14Bios Equity COF, LPBuy54.03K——
2024-08-14Bios Equity COF, LPBuy153.70K——
2024-08-14Bios Equity COF, LPBuy141.46K——
2024-08-14Bios Equity COF, LPBuy3.53K$5.2718.59K
2024-08-14Bios Equity COF, LPSell2.32K$9.0020.92K
2024-08-14Bios Equity COF, LPBuy44.56K——
2024-08-14Bios Equity COF, LPBuy125.00K$8.001.00M
2024-08-14Bios Equity COF, LPBuy23.63K——
2024-08-14Bios Equity COF, LPBuy61.86K——
2024-08-14Bios Equity COF, LPSell307.54K——
2024-08-14Bios Equity COF, LPSell153.70K——
2024-08-14Bios Equity COF, LPSell147.05K——
2024-08-14Bios Equity COF, LPSell44.56K——
2024-08-14Bios Equity COF, LPSell2.09M——
2024-08-14Bios Equity COF, LPSell573.39K——
2024-08-14Bios Equity COF, LPSell3.53K$5.2718.59K
2024-08-14Bios Equity COF, LPSell884.43K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 65, holders +4 vs prior quarter. Ownership 56.62%.

HolderSharesChangeChange %Value
BIOS CAPITAL MANAGEMENT, LP10.05M00.00%15.38M
VOSS CAPITAL, LP1.73M00.00%2.64M
VANGUARD CAPITAL MANAGEMENT LLC393.43K-7.10K-1.77%601.95K
AQR CAPITAL MANAGEMENT LLC127.49K100.38K+370.30%195.06K
GEODE CAPITAL MANAGEMENT, LLC112.55K-115.78K-50.71%172.21K
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC102.61K8.02K+8.48%157.00K
PALOGIC VALUE MANAGEMENT, L.P.100.00K00.00%153.00K
MILLENNIUM MANAGEMENT LLC96.68K96.68KNew147.93K
BLACKROCK, INC.90.03K-337.12K-78.92%137.75K
ABS DIRECT EQUITY FUND LLC73.19K23.19K+46.37%111.97K
ABS INVESTMENT MANAGEMENT LLC73.19K73.19KNew111.97K
VANGUARD FIDUCIARY TRUST CO54.50K-8.10K-12.93%83.38K
ROCK CREEK GROUP LLC39.26K00.00%60.07K
JANE STREET GROUP, LLC39.13K39.13KNew59.87K
HIGHTOWER ADVISORS, LLC36.46K36.46KNew55.78K
GOLDMAN SACHS GROUP INC35.50K23.09K+186.09%54.31K
SFMG, LLC33.00K00.00%50.49K
SUSQUEHANNA INTERNATIONAL GROUP, LLP28.18K28.18KNew43.12K
BRIDGEWAY CAPITAL MANAGEMENT, LLC23.48K-7.50K-24.21%35.93K
STATE STREET CORP21.85K-44.18K-66.91%33.43K
NORTHERN TRUST CORP21.22K-76.63K-78.31%32.47K
MARINER, LLC21.08K21.08KNew32.26K
GLEASON GROUP, INC.19.03K00.00%29.11K
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO18.52K-12.88K-41.02%28.33K
QUBE RESEARCH & TECHNOLOGIES LTD15.26K15.26KNew23.34K

Earnings and financials

Actuate Therapeutics Inc (ACTU) trades at $0.38, with a market cap of $9.20M and a trailing P/E of -0.53. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2022202320242025
0000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Actuate Therapeutics (ACTU) Financials: Revenue & Earnings

ACTU$0.38-0.02 -4.06%

$9.20M

Market Cap

-0.53

P/E

0.30

Forward P/E

66

Score

Price History